The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Radiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in both computing and imaging. The direct integration of magnetic resonance imaging (MRI) with linear accelerators represents an exciting development with the potential to dramatically impact cancer research and treatment. These impacts extend beyond improved imaging and dose deposition. Real-time MRI-guided RT is actively transforming the work flows and capabilities of virtually every aspect of RT. It has the opportunity to change entirely the delivery methods and response assessments of numerous malignancies. This review intends to approach the topic of MRI-based RT guidance from a vendor neutral and international perspective. It also aims to provide an introduction to this topic targeted towards oncologists without a speciality focus in RT. Speciality implications, areas for physician education and research opportunities are identified as they are associated with MRI-guided RT. The uniquely disruptive implications of MRI-guided RT are discussed and placed in context. We further aim to describe and outline important future changes to the speciality of radiation oncology that will occur with MRI-guided RT. The impacts on RT caused by MRI guidance include target identification, RT planning, quality assurance, treatment delivery, training, clinical workflow, tumour response assessment and treatment scheduling. In addition, entirely novel research areas that may be enabled by MRI guidance are identified for future investigation.

[1]  B. Fallone,et al.  First MR images obtained during megavoltage photon irradiation from a prototype integrated linac-MR system. , 2009, Medical physics.

[2]  David A Jaffray,et al.  A facility for magnetic resonance-guided radiation therapy. , 2014, Seminars in radiation oncology.

[3]  T. Bortfeld.  IMRT: a review and preview , 2006, Physics in medicine and biology.

[4]  Yue Cao,et al.  DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy. , 2013, Medical physics.

[5]  Suresh Senan,et al.  MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis. , 2018, International journal of radiation oncology, biology, physics.

[6]  Tianyu Zhao,et al.  Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications. , 2016, International journal of radiation oncology, biology, physics.

[7]  Jan J W Lagendijk,et al.  The magnetic resonance imaging-linac system. , 2014, Seminars in radiation oncology.

[8]  Minsong Cao,et al.  Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Suresh Senan,et al.  Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases. , 2018, International journal of radiation oncology, biology, physics.

[10]  Joseph O. Deasy,et al.  Intravoxel incoherent motion diffusion‐weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.

[11]  Michael Baumann,et al.  Expanding global access to radiotherapy. , 2015, The Lancet. Oncology.

[12]  B. Raaymakers,et al.  Evaluation of Online Plan Adaptation Strategies for the 1.5T MR-linac Based on “First-In-Man” Treatments , 2018, Cureus.

[13]  Sasa Mutic,et al.  Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Hany Soliman,et al.  Evaluation of Glioblastoma Response to Therapy With Chemical Exchange Saturation Transfer. , 2018, International journal of radiation oncology, biology, physics.

[15]  N. Dogan,et al.  Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors , 2018, Cureus.

[16]  Daekeun You,et al.  Temporal Feature Extraction from DCE-MRI to Identify Poorly Perfused Subvolumes of Tumors Related to Outcomes of Radiation Therapy in Head and Neck Cancer , 2016, Tomography.

[17]  W. Curran,et al.  Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.

[18]  Radka Stoyanova,et al.  Daily Tracking of Glioblastoma Resection Cavity, Cerebral Edema, and Tumor Volume with MRI-Guided Radiation Therapy , 2018, Cureus.

[19]  S. Mutic,et al.  Magnetic Resonance Image Guided Radiation Therapy for External Beam Accelerated Partial-Breast Irradiation: Evaluation of Delivered Dose and Intrafractional Cavity Motion. , 2016, International journal of radiation oncology, biology, physics.

[20]  A N T J Kotte,et al.  First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment , 2017, Physics in medicine and biology.

[21]  B. Fallone,et al.  The rotating biplanar linac-magnetic resonance imaging system. , 2014, Seminars in radiation oncology.

[22]  Rob H.N. Tijssen,et al.  Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  G. Stanisz,et al.  Glioblastoma (GBM) effects on quantitative MRI of contralateral normal appearing white matter , 2018, Journal of Neuro-Oncology.

[24]  Jan J W Lagendijk,et al.  MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Sasa Mutic,et al.  The ViewRay system: magnetic resonance-guided and controlled radiotherapy. , 2014, Seminars in radiation oncology.

[26]  Timothy D Johnson,et al.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. Kishan,et al.  Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-60Co teletherapy device. , 2016, The British journal of radiology.

[28]  J. Lagendijk,et al.  Consequences of air around an ionization chamber: Are existing solid phantoms suitable for reference dosimetry on an MR-linac? , 2016, Medical physics.

[29]  D. Low,et al.  Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. , 2017, The British journal of radiology.

[30]  Wenbin Li,et al.  The Role of Intravoxel Incoherent Motion MRI in Predicting Early Treatment Response to Chemoradiation for Metastatic Lymph Nodes in Nasopharyngeal Carcinoma , 2016, Advances in Therapy.

[31]  Marco De Spirito,et al.  Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach , 2018, La radiologia medica.

[32]  G. Stanisz,et al.  Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy , 2018, Scientific Reports.

[33]  Radhe Mohan,et al.  Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  David Bonekamp,et al.  Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  B W Raaymakers,et al.  Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose increase at tissue–air interfaces in a lateral magnetic field due to returning electrons , 2005, Physics in medicine and biology.

[36]  Christian Federau,et al.  Intravoxel incoherent motion MRI as a means to measure in vivo perfusion: A review of the evidence , 2017, NMR in biomedicine.

[37]  Ken-Pin Hwang,et al.  Spatial Precision in Magnetic Resonance Imaging-Guided Radiation Therapy: The Role of Geometric Distortion. , 2016, International journal of radiation oncology, biology, physics.

[38]  H. Vargas,et al.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. , 2016, Radiology.

[39]  Catherine Coolens,et al.  Feasibility of 4D perfusion CT imaging for the assessment of liver treatment response following SBRT and sorafenib , 2016, Advances in radiation oncology.

[40]  Steven J Frank,et al.  Intensity-Modulated Proton Therapy ( IMPT ) versus Intensity-Modulated Photon Radiotherapy ( IMRT ) for Oropharyngeal Cancer : First Comparative Results of Patient-Reported Outcomes , 2016 .

[41]  Sasa Mutic,et al.  Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system , 2017, Advances in radiation oncology.

[42]  F. Bajrović,et al.  Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI , 2016, Clinical Neuroradiology.

[43]  Minsong Cao,et al.  Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy system. , 2016, Medical physics.

[44]  Zhengyang Zhou,et al.  Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy , 2017, Scientific Reports.

[45]  Tianyu Zhao,et al.  Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. , 2016, International journal of radiation oncology, biology, physics.

[46]  Stuart A. Taylor,et al.  Imaging biomarker roadmap for cancer studies , 2016, Nature Reviews Clinical Oncology.

[47]  M. Gaeta,et al.  Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer. , 2014, Academic radiology.

[48]  B W Raaymakers,et al.  Feasibility of MRI guided proton therapy: magnetic field dose effects , 2008, Physics in medicine and biology.

[49]  D. Low,et al.  Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer , 2017, Advances in radiation oncology.

[50]  N. Burnet,et al.  Defining the tumour and target volumes for radiotherapy , 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.

[51]  Deukwoo Kwon,et al.  Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer. , 2019, Practical radiation oncology.

[52]  C. Fuller,et al.  Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. , 2016, International journal of radiation oncology, biology, physics.

[53]  R. Sepponen,et al.  Quantitative rotating frame relaxometry methods in MRI , 2016, NMR in biomedicine.

[54]  Xiaoping Yu,et al.  Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma. , 2018, Clinical radiology.

[55]  Minsong Cao,et al.  Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT. , 2018, The British journal of radiology.

[56]  Lei Tang,et al.  Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. , 2010, Radiology.

[57]  A. Jackson,et al.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.

[58]  Charis Kontaxis,et al.  A new methodology for inter- and intrafraction plan adaptation for the MR-linac , 2015, Physics in medicine and biology.

[59]  Byung Kwan Park,et al.  Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer. , 2012, International journal of radiation oncology, biology, physics.

[60]  B. Erickson,et al.  Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer , 2015, Translational oncology.

[61]  Suresh Senan,et al.  Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy , 2018, Cureus.

[62]  P. Harari,et al.  Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  K. Shin,et al.  Air–electron stream interactions during magnetic resonance IGRT , 2017, Strahlentherapie und Onkologie.

[64]  Masoom A. Haider,et al.  Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations , 2009, Acta oncologica.

[65]  X. Li,et al.  Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. , 2016, Medical physics.

[66]  Stuart Crozier,et al.  The Australian magnetic resonance imaging-linac program. , 2014, Seminars in radiation oncology.

[67]  J G M Kok,et al.  Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept , 2009, Physics in medicine and biology.

[68]  Joshua D. Lawson,et al.  A survey of image‐guided radiation therapy use in the United States , 2010, Cancer.

[69]  B Wu,et al.  An overview of CEST MRI for non-MR physicists , 2016, EJNMMI Physics.

[70]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[71]  C. Fuller,et al.  The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development , 2016, Front. Oncol..

[72]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[73]  Frederik B Laun,et al.  Technical Note: On the size of susceptibility‐induced MR image distortions in prostate and cervix in the context of MR‐guided radiation therapy , 2018, Medical physics.

[74]  D. Jaffray.  Image-guided radiotherapy: from current concept to future perspectives , 2012, Nature Reviews Clinical Oncology.

[75]  Michael C Roach,et al.  Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer , 2019, Cancer medicine.

[76]  Philippe Lambin,et al.  Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.

[77]  Jing Yan,et al.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging , 2016, BMC Cancer.